Table 3.
The therapeutic efficiency of intraperitoneal thermochemotherapy combined with IL-2 immunotherapy
| Groups | n | Intraperitoneal recurrent rate (%) | Hepatic metastasis rate(%) | 3-year survival rate(%) |
| Group I | 65 | 29.2(19/65) | 16.9(11/65) | 47.7(31/65) |
| Group II | 73 | 12.3(9/73)b | 10.9(8/73)a | 65.8(48/73)a |
P < 0.05 vs control group,
P < 0.01 vs control group